Severe Malaria 2019 Abuja Stakeholder Meeting Report

21-22 Oct 2019

The meeting brought together delegations representing 19 countries:  Angola, Benin, Burkina Faso, CAR, Congo, DRC, Ethiopia, Ghana, Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Nigeria, Sierra  Leone, Uganda, Zambia and Zimbabwe, and 15 partner organizations, including RBM, Unitaid, PMI USAID, Global Fund, UNICEF, MSH, Swiss TPH, Akena, KSPH, CRS, Makarere University, MSF, PSI, WHO and the Malaria Consortium. 

Medicines for Malaria Venture (MMV) and the Clinton Health Access Initiative (CHAI) convened a Severe Malaria Global Stakeholder Meeting, under the auspices of the RBM Case Management Working Group and in collaboration with UNICEF, Swiss Tropical and Public Health Institute (Swiss TPH) and Médecins Sans Frontières (MSF). The meeting was hosted by the Nigerian Ministry of Health in Abuja, Nigeria and held on the 21st and 22nd of October, 2019.  This was the first meeting convened on severe malaria case management, building on stakeholder meetings focused on Injectable artesunate (Inj AS) and artesunate rectal capsules (ARC) in 2011 and 2016, respectively. The meeting assembled countries that have commenced the process of rolling out rectal artesunate within their systems of severe malaria care.